Abstract:Pathogenic hantaviruses, genus Orthohantaviridae, are maintained in rodent reservoirs with zoonotic transmission to humans occurring through inhalation of rodent excreta. Hantavirus disease in humans is characterized by localized vascular leakage and elevated levels of circulating proinflammatory cytokines. Despite the constant potential for deadly zoonotic transmission to humans, specific virus-host interactions of hantaviruses that lead to innate immune activation, and how these processes impart disease, remain unclear. In this study, we examined the mechanisms of viral recognition and innate immune activation of Hantaan orthohantavirus (HTNV) infection. We identified the RIG-I-like receptor (RLR) pathway as essential for innate immune activation, interferon (IFN) production, and interferon stimulated gene (ISG) expression in response to HTNV infection in human endothelial cells, and in murine cells representative of a non-reservoir host. Our results demonstrate that innate immune activation and signaling through the RLR pathway depends on viral replication wherein the host response can significantly restrict replication in target cells in a manner dependent on the type 1 interferon receptor (IFNAR). Importantly, following HTNV infection of a non-reservoir host murine model, IFNAR-deficient mice had higher viral loads, increased persistence, and greater viral dissemination to lung, spleen, and kidney compared to wild-type animals. Surprisingly, this response was MAVS independent in vivo. Innate immune profiling in these tissues demonstrates that HTNV infection triggers expression of IFN-regulated cytokines early during infection. We conclude that the RLR pathway is essential for recognition of HTNV infection to direct innate immune activation and control of viral replication in vitro, and that additional virus sensing and innate immune response pathways of IFN and cytokine regulation contribute to control of HTNV in vivo. These results reveal a critical role for innate immune regulation in driving divergent outcomes of HTNV infection, and serve to inform studies to identify therapeutic targets to alleviate human hantavirus disease.Human pathogenic hantaviruses are endemic in rodent reservoir hosts worldwide. Incidental pathogenic human hantavirus infection has a case-fatality rate of up to 38%. Although Hantaan orthohantavirus (HTNV) is a major cause of human hemorrhagic fevers in Asia, the mechanisms underlying innate immune activation in human target endothelial cells remain unknown. Here, we find that the host cytoplasmic pathogen recognition receptors, RIG-I and MDA5, are essential for induction of antiviral proteins and control of HTNV replication in human and non-reservoir murine cells. Type I interferon, but not type III interferon, is induced in response to live virus infection, and can limit HTNV replication in these cells. We further demonstrate that type I interferon signaling is required for rapid control of virus replication and dissemination in non-reservoir murine hosts in vivo. Importantly, a role for type I interferon-independent mechanisms of antiviral induction in vivo was also revealed. This work provides deeper understanding of how differential host responses to HTNV infection contribute to infection outcomes and is essential to identify targets for therapeutic interventions to mitigate human hantavirus disease.

In vivo study on the interactions between Syk and HTNV G1 ITAM-like sequence of Hantaan virus

[Identification of a Functional ITAM-like Sequence Within G1 Cytoplasmic Tail of Hantaan Virus].

T-cell immunoglobulin and mucin 1 (TIM-1) mediates infection of Hantaan virus in Jurkat T cells

Integrative Analysis of HTNV Glycoprotein Derived MHC II Epitopes by <i>In Silico</i> Prediction and Experimental Validation

Cellular entry of Hantaan virus A9 strain: Specific interactions with β3 integrins and a novel 70kDa protein

Screening and Identification of an H-2Kb-Restricted CTL Epitope Within the Glycoprotein of Hantaan Virus

Involvement of the Akt/NF-κB Pathways in the HTNV-Mediated Increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs

Comparative Immunoreactivity Analyses of Hantaan Virus Glycoprotein-Derived MHC-I Epitopes in Vaccination

Study on the Interaction of Hantavirus Envelope G2 Protein with Β3 Intergrin in Vivo

RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication

Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor

Hantaan Virus Triggers Tlr4-Dependent Innate Immune Responses

Hantaan Virus Inhibits Type I Interferon Response by Targeting RLR Signaling Pathways Through TRIM25

IFN-λs inhibit Hantaan virus infection through the JAK-STAT pathway and expression of Mx2 protein

IL-15 induced bystander activation of CD8+ T cells may mediate endothelium injury through NKG2D in Hantaan virus infection

Hantaan virus inhibits type I interferon response by targeting RLRs signaling pathways through TRIM25

HTNV Sensitizes Host Toward TRAIL-Mediated Apoptosis-A Pivotal Anti-hantaviral Role of TRAIL.

The Glycoprotein and Nucleocapsid Protein of Hantaviruses Manipulate Autophagy Flux to Restrain Host Innate Immune Responses

Dysregulation of the β3 integrin-VEGFR2 complex in Hantaan virus–directed hyperpermeability upon treatment with VEGF

Construction and identification of hantaan pseudovirions

Hantaan virus-derived peptides that stabilize HLA-E could abrogate inhibition of CD56dimNKG2A+ NK cells